Yes No2! . . . the Q&A portion of the cc, while somewhat short . . . was quite informative! . . . and REVEALING! . . . as Potted's leaves were "tuned" for the best reception! . . . http://www.isispharm.com/
For a partnered drug candidate ( ATL/TV1102 ) . . . Stan really seemed to be "the expert" on the VLA-4 target "mode-of-action" . . . ( VLA-4 is a clinically validated target in MS ) . . . how it compares with Tysabri . . . and the potential benefits of this 2nd Gen. Antisense drug! . . . without over-stating where they are - - they still have a lot of work to do! . . . perhaps lower doses are in order . . . since the Antisense drug had such strong efficacy with only 8 weeks of treatment!